122 related articles for article (PubMed ID: 36563676)
21. Serine Protease Inhibitor Kazal Type 1, A Potential Biomarker for the Early Detection, Targeting, and Prediction of Response to Immune Checkpoint Blockade Therapies in Hepatocellular Carcinoma.
Jia J; Ga L; Liu Y; Yang Z; Wang Y; Guo X; Ma R; Liu R; Li T; Tang Z; Wang J
Front Immunol; 2022; 13():923031. PubMed ID: 35924241
[TBL] [Abstract][Full Text] [Related]
22. Cancer-derived sialylated IgG promotes tumor immune escape by binding to Siglecs on effector T cells.
Wang Z; Geng Z; Shao W; Liu E; Zhang J; Tang J; Wang P; Sun X; Xiao L; Xu W; Zhang Y; Cui H; Zhang L; Yang X; Chang X; Qiu X
Cell Mol Immunol; 2020 Nov; 17(11):1148-1162. PubMed ID: 31754235
[TBL] [Abstract][Full Text] [Related]
23. Nanoparticle-Mediated Delivery of 2-Deoxy-D-Glucose Induces Antitumor Immunity and Cytotoxicity in Liver Tumors in Mice.
Sasaki K; Nishina S; Yamauchi A; Fukuda K; Hara Y; Yamamura M; Egashira K; Hino K
Cell Mol Gastroenterol Hepatol; 2021; 11(3):739-762. PubMed ID: 33191170
[TBL] [Abstract][Full Text] [Related]
24. IgG Fc sialylation is regulated during the germinal center reaction following immunization with different adjuvants.
Bartsch YC; Eschweiler S; Leliavski A; Lunding HB; Wagt S; Petry J; Lilienthal GM; Rahmöller J; de Haan N; Hölscher A; Erapaneedi R; Giannou AD; Aly L; Sato R; de Neef LA; Winkler A; Braumann D; Hobusch J; Kuhnigk K; Krémer V; Steinhaus M; Blanchard V; Gemoll T; Habermann JK; Collin M; Salinas G; Manz RA; Fukuyama H; Korn T; Waisman A; Yogev N; Huber S; Rabe B; Rose-John S; Busch H; Berberich-Siebelt F; Hölscher C; Wuhrer M; Ehlers M
J Allergy Clin Immunol; 2020 Sep; 146(3):652-666.e11. PubMed ID: 32445838
[TBL] [Abstract][Full Text] [Related]
25. PIM2 Expression Induced by Proinflammatory Macrophages Suppresses Immunotherapy Efficacy in Hepatocellular Carcinoma.
Wang JC; Chen DP; Lu SX; Chen JB; Wei Y; Liu XC; Tang YH; Zhang R; Chen JC; Kan A; Xu L; Zhang YJ; Hou J; Kuang DM; Chen MS; Zhou ZG
Cancer Res; 2022 Sep; 82(18):3307-3320. PubMed ID: 35802648
[TBL] [Abstract][Full Text] [Related]
26. Enrichment of sialylated IgG by lectin fractionation does not enhance the efficacy of immunoglobulin G in a murine model of immune thrombocytopenia.
Guhr T; Bloem J; Derksen NI; Wuhrer M; Koenderman AH; Aalberse RC; Rispens T
PLoS One; 2011; 6(6):e21246. PubMed ID: 21731683
[TBL] [Abstract][Full Text] [Related]
27. Nanobubbles containing PD-L1 Ab and miR-424 mediated PD-L1 blockade, and its expression inhibition to enable and potentiate hepatocellular carcinoma immunotherapy in mice.
Liu Y; Xie Q; Ma Y; Lin C; Li J; Hu B; Liu C; Zhao Y
Int J Pharm; 2022 Dec; 629():122352. PubMed ID: 36374798
[TBL] [Abstract][Full Text] [Related]
28. Human DC-SIGN and CD23 do not interact with human IgG.
Temming AR; Dekkers G; van de Bovenkamp FS; Plomp HR; Bentlage AEH; Szittner Z; Derksen NIL; Wuhrer M; Rispens T; Vidarsson G
Sci Rep; 2019 Jul; 9(1):9995. PubMed ID: 31292524
[TBL] [Abstract][Full Text] [Related]
29. Hydrazide-manganese coordinated multifunctional nanoplatform for potentiating immunotherapy in hepatocellular carcinoma.
Hou G; Qian J; Guo M; Xu W; Wang J; Wang Y; Suo A
J Colloid Interface Sci; 2022 Dec; 628(Pt B):968-983. PubMed ID: 36037718
[TBL] [Abstract][Full Text] [Related]
30. Combination immunotherapy strategies for glioblastoma.
Chan HY; Choi J; Jackson C; Lim M
J Neurooncol; 2021 Feb; 151(3):375-391. PubMed ID: 33611705
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of FcγR-mediated phagocytosis by IVIg is independent of IgG-Fc sialylation and FcγRIIb in human macrophages.
Nagelkerke SQ; Dekkers G; Kustiawan I; van de Bovenkamp FS; Geissler J; Plomp R; Wuhrer M; Vidarsson G; Rispens T; van den Berg TK; Kuijpers TW
Blood; 2014 Dec; 124(25):3709-18. PubMed ID: 25352126
[TBL] [Abstract][Full Text] [Related]
32. Estrogen induces St6gal1 expression and increases IgG sialylation in mice and patients with rheumatoid arthritis: a potential explanation for the increased risk of rheumatoid arthritis in postmenopausal women.
Engdahl C; Bondt A; Harre U; Raufer J; Pfeifle R; Camponeschi A; Wuhrer M; Seeling M; Mårtensson IL; Nimmerjahn F; Krönke G; Scherer HU; Forsblad-d'Elia H; Schett G
Arthritis Res Ther; 2018 May; 20(1):84. PubMed ID: 29720252
[TBL] [Abstract][Full Text] [Related]
33. Modeling resistance of colorectal peritoneal metastases to immune checkpoint blockade in humanized mice.
Küçükköse E; Heesters BA; Villaudy J; Verheem A; Cercel M; van Hal S; Boj SF; Borel Rinkes IHM; Punt CJA; Roodhart JML; Laoukili J; Koopman M; Spits H; Kranenburg O
J Immunother Cancer; 2022 Dec; 10(12):. PubMed ID: 36543378
[TBL] [Abstract][Full Text] [Related]
34. The interferon-stimulated gene RIPK1 regulates cancer cell intrinsic and extrinsic resistance to immune checkpoint blockade.
Cucolo L; Chen Q; Qiu J; Yu Y; Klapholz M; Budinich KA; Zhang Z; Shao Y; Brodsky IE; Jordan MS; Gilliland DG; Zhang NR; Shi J; Minn AJ
Immunity; 2022 Apr; 55(4):671-685.e10. PubMed ID: 35417675
[TBL] [Abstract][Full Text] [Related]
35. Targeting DNA Damage Response and Immune Checkpoint for Anticancer Therapy.
Huang JL; Chang YT; Hong ZY; Lin CS
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328658
[TBL] [Abstract][Full Text] [Related]
36. Responsive Multivesicular Polymeric Nanovaccines that Codeliver STING Agonists and Neoantigens for Combination Tumor Immunotherapy.
Su T; Cheng F; Qi J; Zhang Y; Zhou S; Mei L; Fu S; Zhang F; Lin S; Zhu G
Adv Sci (Weinh); 2022 Aug; 9(23):e2201895. PubMed ID: 35712773
[TBL] [Abstract][Full Text] [Related]
37. Interferon Signaling Is Diminished with Age and Is Associated with Immune Checkpoint Blockade Efficacy in Triple-Negative Breast Cancer.
Sceneay J; Goreczny GJ; Wilson K; Morrow S; DeCristo MJ; Ubellacker JM; Qin Y; Laszewski T; Stover DG; Barrera V; Hutchinson JN; Freedman RA; Mittendorf EA; McAllister SS
Cancer Discov; 2019 Sep; 9(9):1208-1227. PubMed ID: 31217296
[TBL] [Abstract][Full Text] [Related]
38. Systematic Assessment of Transcriptomic Biomarkers for Immune Checkpoint Blockade Response in Cancer Immunotherapy.
Sun S; Xu L; Zhang X; Pang L; Long Z; Deng C; Zhu J; Zhou S; Wan L; Pang B; Xiao Y
Cancers (Basel); 2021 Apr; 13(7):. PubMed ID: 33915876
[TBL] [Abstract][Full Text] [Related]
39. Sialylation of anti-histone immunoglobulin G autoantibodies determines their capabilities to participate in the clearance of late apoptotic cells.
Magorivska I; Muñoz LE; Janko C; Dumych T; Rech J; Schett G; Nimmerjahn F; Bilyy R; Herrmann M
Clin Exp Immunol; 2016 Apr; 184(1):110-7. PubMed ID: 26618514
[TBL] [Abstract][Full Text] [Related]
40. Sialylated immunoglobulin G: a promising diagnostic and therapeutic strategy for autoimmune diseases.
Li D; Lou Y; Zhang Y; Liu S; Li J; Tao J
Theranostics; 2021; 11(11):5430-5446. PubMed ID: 33859756
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
